The expression and clinical significance of high mobility group nucleosome binding domain 5 in human osteosarcoma

Tumor Biology

Volumn 35, Issue 7, 2014, Pages 6539-6547

  Zhou, Xuhui ^a   Yuan, Bo ^b   Yuan, Wen ^a   Wang, Ce ^a   Gao, Rui ^a   Wang, Junyan ^a  

^a SHANGHAI UNIVERSITY   (China)

^b Interventional Therapeutic Center   (China)

Author keywords

AKT; Invasion; Nucleosome binding protein; Osteosarcoma; Proliferation

Indexed keywords

CASPASE 3; CYCLIN B1; GELATINASE B; HIGH MOBILITY GROUP PROTEIN;

ADULT; AGED; APOPTOSIS; ARTICLE; CANCER STAGING; CELL CYCLE ARREST; CELL VIABILITY; ENZYME ACTIVITY; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; METASTASIS; NUCLEOSOME; OSTEOSARCOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR INVASION; WESTERN BLOTTING;

ADULT; AGED; APOPTOSIS; BONE NEOPLASMS; CELL CYCLE CHECKPOINTS; CELL LINE, TUMOR; CELL PROLIFERATION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HMGN PROTEINS; HUMANS; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; ONCOGENE PROTEIN V-AKT; OSTEOSARCOMA; RNA INTERFERENCE; TRANS-ACTIVATORS;

EID: 84905000466     PISSN: 10104283     EISSN: 14230380     Source Type: Journal    
DOI: 10.1007/s13277-014-1825-0     Document Type: Article

References (25)

1. Huang J, Ni J, Liu K, Yu Y, Xie M, Kang R, et al. HMGB1 promotes drug resistance in osteosarcoma. Cancer Res. 2012;72(1):230-8. doi:10.1158/0008-5472. CAN-11-2001.
2. Meyers PA, Schwartz CL, Krailo MD, Healey JH, Bernstein ML, Betcher D, et al. Osteosarcoma: the addition of muramyl tripeptide to chemotherapy improves overall survival - a report from the Children's Oncology Group. J Clin Oncol. 2008;26(4):633-8. doi:10.1200/JCO.2008.14.0095. (Pubitemid 351264359)
3. Gill M, McCarthy M, Murrells T, Silcocks P. Chemotherapy for the primary treatment of osteosarcoma: population effectiveness over 20 years. Lancet. 1988;1(8587):689-92. (Pubitemid 18083273)
4. Bustin M, Reeves R. High-mobility-group chromosomal proteins: architectural components that facilitate chromatin function. Prog Nucleic Acid Res Mol Biol. 1996;54:35-100.
5. Bustin M. Regulation of DNA-dependent activities by the functional motifs of the high-mobility-group chromosomal proteins. Mol Cell Biol. 1999;19(8):5237-46. (Pubitemid 29339883)
6. Pritsker M, Ford NR, Jenq HT, Lemischka IR. Genomewide gain-of-function genetic screen identifies functionally active genes in mouse embryonic stem cells. Proc Natl Acad Sci U S A. 2006;103(18):6946-51. doi:10.1073/pnas. 0509861103.
7. Huang C, Zhou LQ, Song G. Effect of nucleosomal binding protein 1 in androgen-independent prostatic carcinoma. Zhonghua Yi Xue Za Zhi. 2008;88(10):657-60. (Pubitemid 351756610)
8. Green J, Ikram M, Vyas J, Patel N, Proby CM, Ghali L, et al. Overexpression of the Axl tyrosine kinase receptor in cutaneous SCC-derived cell lines and tumours. Br J Cancer. 2006;94(10):1446-51. doi:10.1038/sj.bjc. 6603135. (Pubitemid 43772279)
9. Tang WY, Newbold R, Mardilovich K, Jefferson W, Cheng RY, Medvedovic M, et al. Persistent hypomethylation in the promoter of nucleosomal binding protein 1 (Nsbp1) correlates with overexpression of Nsbp1 in mouse uteri neonatally exposed to diethylstilbestrol or genistein. Endocrinology. 2008;149(12):5922-31. doi:10.1210/en.2008-0682.
10. Li DQ, Hou YF, Wu J, Chen Y, Lu JS, Di GH, et al. Gene expression profile analysis of an isogenic tumour metastasis model reveals a functional role for oncogene AF1Q in breast cancer metastasis. Eur J Cancer. 2006;42(18):3274-86. doi:10.1016/j.ejca.2006.07.008. (Pubitemid 44872944)
11. Wahafu W, He ZS, Zhang XY, Zhang CJ, Yao K, Hao H, et al. The nucleosome binding protein NSBP1 is highly expressed in human bladder cancer and promotes the proliferation and invasion of bladder cancer cells. Tumour Biol. 2011;32(5):931-9. doi:10.1007/s13277-011-0195-0.
12. Ji SQ, Yao L, Zhang XY, Li XS, Zhou LQ. Knockdown of the nucleosome binding protein 1 inhibits the growth and invasion of clear cell renal cell carcinoma cells in vitro and in vivo. J Exp Clin Cancer Res. 2012;31:22. doi:10.1186/1756-9966-31-22.
13. Rochman M, Malicet C, Bustin M. HMGN5/NSBP1: a new member of the HMGN protein family that affects chromatin structure and function. Biochim Biophys Acta. 2010;1799(1-2):86-92. doi:10.1016/j.bbagrm.2009.09.012.
14. Chiu CC, Lin CH, Fang K. Etoposide (VP-16) sensitizes p53-deficient human non-small cell lung cancer cells to caspase-7-mediated apoptosis. Apoptosis. 2005;10(3):643-50. doi:10.1007/s10495-005-1898-8. (Pubitemid 40896669)
15. Li B, Yang Y, Jiang S, Ni B, Chen K, Jiang L. Adenovirus-mediated overexpression of BMP-9 inhibits human osteosarcoma cell growth and migration through downregulation of the PI3K/AKT pathway. Int J Oncol. 2012;41(5):1809-19. doi:10.3892/ijo.2012.1617.
16. Evan GI, Vousden KH. Proliferation, cell cycle and apoptosis in cancer. Nature. 2001;411(6835):342-8. doi:10.1038/3507721335077213. (Pubitemid 32467043)
17. Harper JW, Adami GR, Wei N, Keyomarsi K, Elledge SJ. The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell. 1993;75(4):805-16. (Pubitemid 23346377)
18. Liu SY, Chen CL, Yang TT, Huang WC, Hsieh CY, Shen WJ, et al. Albumin prevents reactive oxygen species-induced mitochondrial damage, autophagy, and apoptosis during serum starvation. Apoptosis. 2012;17(11):1156-69. doi:10.1007/s10495-012-0758-6.
19. Yang YH, Chen K, Li B, Chen JW, Zheng XF, Wang YR, et al. Estradiol inhibits osteoblast apoptosis via promotion of autophagy through the ER-ERK-mTOR pathway. Apoptosis. 2013;18(11):1363-75. doi:10.1007/s10495-013-0867-x.
20. King LM, Francomano CA. Characterization of a human gene encoding nucleosomal binding protein NSBP1. Genomics. 2001;71(2):163-73. doi:10.1006/geno.2000.6443. (Pubitemid 32165083)
21. Hock R, Furusawa T, Ueda T, Bustin M. HMG chromosomal proteins in development and disease. Trends Cell Biol. 2007;17(2):72-9. doi:10.1016/j.tcb. 2006.12.001. (Pubitemid 46206113)
22. Nielsen-Preiss SM, Silva SR, Gillette JM. Role of PTEN and Akt in the regulation of growth and apoptosis in human osteoblastic cells. J Cell Biochem. 2003;90(5):964-75. doi:10.1002/jcb.10709. (Pubitemid 37467112)
23. Pines J, Hunter T. Human cyclins A and B1 are differentially located in the cell and undergo cell cycle-dependent nuclear transport. J Cell Biol. 1991;115(1):1-17. (Pubitemid 21909889)
24. Symonds H, Krall L, Remington L, Saenz-Robles M, Lowe S, Jacks T, et al. p53-dependent apoptosis suppresses tumor growth and progression in vivo. Cell. 1994;78(4):703-11.
25. Wittig JC, Bickels J, Priebat D, Jelinek J, Kellar-Graney K, Shmookler B, et al. Osteosarcoma: a multidisciplinary approach to diagnosis and treatment. Am Fam Physician. 2002;65(6):1123-32.